Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Raymond James Financial
(NY:
RJF
)
110.18
+1.27 (+1.17%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Raymond James Financial
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Raymond James Just Raised Its Price Target on Nvidia (NVDA) Stock
April 11, 2024
Nvidia stock is on the move Thursday after shares of NVDA got an increased price target of $1,100 from Raymond James analysts.
Via
InvestorPlace
Deep Dive Into Raymond James Finl Stock: Analyst Perspectives (4 Ratings)
April 09, 2024
Via
Benzinga
Alpha Fit Club Headlines Red Bank Classic 5K Set for June 15
April 08, 2024
Business Community Gears Up for Fifth Edition of Charity Run/Walk Supporting Water Safety Education for Borough YouthRED BANK, N.J. - April 8, 2024 - PRLog -- Red Bank RiverCenter is pleased to...
Via
PRLog
Is Estée Lauder on the Verge Of a Massive Comeback?
April 04, 2024
There has been a seemingly endless run of analyst upgrades of Estée Lauder stock in recent months, and it's effectively been all one-way traffic.
Via
MarketBeat
3 Companies Buying Back Stock Before New Highs
April 01, 2024
Three stocks that seemed cheap enough for insiders to buy are also calling Wall Street analysts attention for potentially higher prices in the coming months
Via
MarketBeat
Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says
March 28, 2024
Raymond James resumes coverage of Amgen highlighting its diversified portfolio and strong presence across therapeutic areas for sustainable long-term growth. Innovative pipeline in oncology, rare...
Via
Benzinga
The Dividend Dream Team: 3 Stocks Delivering Dependable Payouts
March 27, 2024
Dividend stocks PepsiCo, Starbucks, and ONEOK are ideal for investors seeking dependable payouts in a volatile market environment.
Via
InvestorPlace
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,100 Today
March 26, 2024
Via
Benzinga
Evaluating Raymond James Finl: Insights From 8 Financial Analysts
March 22, 2024
Via
Benzinga
Peering Into Raymond James Finl's Recent Short Interest
March 04, 2024
Via
Benzinga
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
March 25, 2024
Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer.
Via
Benzinga
Raymond James Financial Inc. (NYSE: RJF) Highlighted for Surprising Price Action
March 21, 2024
Via
Investor Brand Network
Raymond James Financial Names Paul Shoukry President and CEO Successor, Announces Additional Key Leadership Changes
March 19, 2024
From
Raymond James Financial
Via
GlobeNewswire
Reflections From The Middle Seat: An Allocators Journey To Private Capital Advisory
March 19, 2024
I left a limited partner seat in April 2022 to join the Private Capital Advisory team at Raymond James and have received many questions weekly since from both LPs and General Partners.
Via
Talk Markets
Expert Ratings For Raymond James Finl
January 25, 2024
Via
Benzinga
Best Stocks To Watch This Week - Sunday, March 17
March 17, 2024
In this video, I review the week's trading and discuss which stocks would be the best to keep an eye on as we move into the new week of trading.
Via
Talk Markets
Raymond James Maintains Outperform Rating for Host Hotels & Resorts: Here's What You Need To Know
March 15, 2024
Via
Benzinga
Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock
February 23, 2024
From
Raymond James Financial
Via
GlobeNewswire
Bears covered shorts on this ETF, 3 stocks to pop on the shift
February 21, 2024
Bears have ditched their short positions on this ETF, admitting that they too see a bull case for the economy, and these are the stocks to get paid first
Via
MarketBeat
Topics
Bonds
ETFs
Economy
Exposures
Debt Markets
Economy
Raymond James Is Souring on Carvana (CVNA) Stock
February 16, 2024
Raymond James issued a "sell" rating on Carvana. Here’s why betting against CVNA stock is a complicated proposition.
Via
InvestorPlace
Raymond James Maintains Strong Buy Rating for Patterson-UTI Energy: Here's What You Need To Know
February 16, 2024
Via
Benzinga
Stock Market Boom: Top 3 Financial Stocks to Ride the Rally
February 13, 2024
The bull market will cause much more wealth to enter stocks, Here are three of the top names poised to benefit from a financial stocks boom.
Via
InvestorPlace
This Analyst Downgrades Tractor Supply Despite EPS Beat, Cites Short-Term Hurdles
February 02, 2024
Raymond James analyst Bobby Griffin downgrades Tractor Supply to Outperform, citing near-term earnings challenges post Q4 results. Despite a slight miss in sales and a beat in adjusted EPS, the analyst...
Via
Benzinga
Why Snowflake Stock Is Trading At New 52-Week High
February 02, 2024
Raymond James noted current public cloud trends as positive and specifically highlighted Amazon.com's fourth-quarter AWS revenue growth re-acceleration as favorable to Snowflake as its Cloud Data...
Via
Benzinga
Fastly, General Mills And 2 Other Stocks Insiders Are Selling
February 01, 2024
The Nasdaq 100 closed lower by more than 300 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Raymond James Maintains Strong Buy Rating for Marathon Petroleum: Here's What You Need To Know
January 31, 2024
Via
Benzinga
Yes, Colgate-Palmolive can clean its way to a fresh all-time high
January 30, 2024
Colgate-Palmolive is in an upswing driven by analysts' sentiment and results; it may experience a price-multiple expansion and hit new highs this year
Via
MarketBeat
Colgate's Bright Smile: Analyst Envisions Upswing In 2024 Guidance With Ample Growth Opportunities
January 29, 2024
Raymond James analyst upgrades Colgate-Palmolive to Outperform and announces $91 price target. Strong Q4 earnings and 2024 outlook cited.
Via
Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Raymond James Finl: Here's What You Need To Know
January 29, 2024
Via
Benzinga
Abbott Laboratories on track for new highs in 2024
January 25, 2024
Abbott Laboratories is a solid dividend play whose underlying business is returning to growth after years of COVID-19 impact.
Via
MarketBeat
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.